These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7398098)
1. Domperidone: a novel agent for the investigation of anterior pituitary function and control in man. Pourmand M; Rodriguez-Arnao MD; Weightman DR; Hall R; Cook DB; Lewis M; Scanlon MF Clin Endocrinol (Oxf); 1980 Feb; 12(2):211-5. PubMed ID: 7398098 [TBL] [Abstract][Full Text] [Related]
2. Increased thyrotrophin and prolactin secretion induced by domperidone in hypothyroid subjects. Massara F; Camanni F; Amoroso A; Molinatti GM; Müller EE Acta Endocrinol (Copenh); 1981 May; 97(1):48-53. PubMed ID: 7223316 [TBL] [Abstract][Full Text] [Related]
3. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201 [TBL] [Abstract][Full Text] [Related]
4. Domperidone, an extracerebral inhibitor of dopamine receptors, stimulates thyrotropin and prolactin release in man. Delitala G; Devilla L; Lotti G J Clin Endocrinol Metab; 1980 Jun; 50(6):1127-30. PubMed ID: 7372791 [TBL] [Abstract][Full Text] [Related]
5. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations. Besser GM; Delitala G; Grossman A; Stubbs WA; Yeo T Br J Pharmacol; 1980; 71(2):569-73. PubMed ID: 6110459 [TBL] [Abstract][Full Text] [Related]
6. On the role of dopamine receptors in the central regulation of human TSH. Delitala G; Devilla L; Canessa A; D'Asta F Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078 [TBL] [Abstract][Full Text] [Related]
7. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects. Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595 [TBL] [Abstract][Full Text] [Related]
8. Pituitary hormone secretion after inhibition of L-aromatic amino acid decarboxylase activity in man. Delitala G; Devilla L; Pende A Acta Endocrinol (Copenh); 1980 Dec; 95(4):438-43. PubMed ID: 7456974 [TBL] [Abstract][Full Text] [Related]
9. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin. Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061 [TBL] [Abstract][Full Text] [Related]
10. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia. Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194 [TBL] [Abstract][Full Text] [Related]
11. Prolactin-releasing effect of a novel anti-dopaminergic drug, domperidone, in the rat. Cocchi D; Gil-Ad I; Parenti M; Stefanini E; Locatelli V; Müller EE Neuroendocrinology; 1980; 30(2):65-9. PubMed ID: 7354891 [No Abstract] [Full Text] [Related]
12. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone. Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740 [TBL] [Abstract][Full Text] [Related]
13. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests. Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia. Peters JR; Rodriguez-Arnao MD; Foord SM; Edwards C; Dieguez C; Woodhead S; Hall R; Scanlon MF J Endocrinol Invest; 1985 Apr; 8(2):163-6. PubMed ID: 4031383 [TBL] [Abstract][Full Text] [Related]
15. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia. Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of inhibitory action of kainic acid on prolactin secretion in male rats. Pinilla L; Gonzalez D; Tena-Sempere M; Aguilar R; Aguilar E J Endocrinol; 1996 Oct; 151(1):159-67. PubMed ID: 8943780 [TBL] [Abstract][Full Text] [Related]
17. Effect of domperidone on prolactin (PRL)and thyrotrophin (TSH) secretion. Kaufman JM; Elewaut A; Vermeulen A Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):293-303. PubMed ID: 6802092 [TBL] [Abstract][Full Text] [Related]
18. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery. Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297 [TBL] [Abstract][Full Text] [Related]
19. Dopamine inhibition of action potentials in a prolactin secreting cell line is modulated by oestrogen. Dufy B; Vincent JD; Fleury H; Du Pasquier P; Gourdji D; Tixier-Vidal A Nature; 1979 Dec 20-27; 282(5741):855-7. PubMed ID: 117385 [TBL] [Abstract][Full Text] [Related]
20. The effect of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pregnant rats. Haisenleder DJ; Moy JA; Gala RR; Lawson DM Endocrinology; 1986 Nov; 119(5):1980-8. PubMed ID: 3095096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]